PL4271359T3 - Kompozycja proszku ulegającego rozpadowi w jamie ustnej - Google Patents
Kompozycja proszku ulegającego rozpadowi w jamie ustnejInfo
- Publication number
- PL4271359T3 PL4271359T3 PL21839271.0T PL21839271T PL4271359T3 PL 4271359 T3 PL4271359 T3 PL 4271359T3 PL 21839271 T PL21839271 T PL 21839271T PL 4271359 T3 PL4271359 T3 PL 4271359T3
- Authority
- PL
- Poland
- Prior art keywords
- powder composition
- dispersible powder
- orally dispersible
- orally
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20383177.1A EP4023210A1 (en) | 2020-12-30 | 2020-12-30 | Orodispersible powder composition |
| PCT/IB2021/062096 WO2022144691A1 (en) | 2020-12-30 | 2021-12-21 | Orodispersible powder composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4271359T3 true PL4271359T3 (pl) | 2026-05-11 |
Family
ID=74205598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21839271.0T PL4271359T3 (pl) | 2020-12-30 | 2021-12-21 | Kompozycja proszku ulegającego rozpadowi w jamie ustnej |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12582601B2 (pl) |
| EP (2) | EP4023210A1 (pl) |
| JP (1) | JP2024501157A (pl) |
| CN (1) | CN116635013A (pl) |
| ES (1) | ES3064347T3 (pl) |
| PL (1) | PL4271359T3 (pl) |
| WO (1) | WO2022144691A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024227385A1 (en) * | 2024-03-28 | 2025-10-16 | Athena Pharmaceutiques Sas | Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof |
| EP4702971A1 (en) * | 2024-09-03 | 2026-03-04 | Athena Pharmaceutiques SAS | Method for preparation of lisdexamfetamine dimesylate dispersible tablet |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0002019A1 (de) | 1977-11-14 | 1979-05-30 | Ciba-Geigy Ag | Verfahren zur Herstellung von Organozinnverbindungen |
| US20060024335A1 (en) * | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
| US20060198885A1 (en) | 2005-02-22 | 2006-09-07 | Sun Pharmaceutical Industries Ltd. | Oral pharmaceutical composition |
| WO2007078726A2 (en) * | 2005-12-16 | 2007-07-12 | Merck & Co., Inc. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| EP2538923A2 (en) * | 2010-02-22 | 2013-01-02 | Lupin Limited | Taste-masked powder for suspension compositions of methylprednisolone |
| EP2948170B1 (en) * | 2013-01-23 | 2020-08-19 | Alvine Pharmaceuticals, Inc. | Pharmaceutical compositions for treating celiac disease and gluten intolerance |
| CN111632023A (zh) * | 2014-03-27 | 2020-09-08 | Ucb法奇姆股份有限公司 | 包含左西替利嗪的药物组合物 |
| WO2015200842A1 (en) * | 2014-06-26 | 2015-12-30 | MicroBiome Therapeutics LLC | Composition comprising metformin and a microbiome modulator |
-
2020
- 2020-12-30 EP EP20383177.1A patent/EP4023210A1/en not_active Withdrawn
-
2021
- 2021-12-21 ES ES21839271T patent/ES3064347T3/es active Active
- 2021-12-21 PL PL21839271.0T patent/PL4271359T3/pl unknown
- 2021-12-21 CN CN202180088572.8A patent/CN116635013A/zh active Pending
- 2021-12-21 EP EP21839271.0A patent/EP4271359B1/en active Active
- 2021-12-21 WO PCT/IB2021/062096 patent/WO2022144691A1/en not_active Ceased
- 2021-12-21 US US18/255,675 patent/US12582601B2/en active Active
- 2021-12-21 JP JP2023533355A patent/JP2024501157A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022144691A1 (en) | 2022-07-07 |
| JP2024501157A (ja) | 2024-01-11 |
| EP4271359C0 (en) | 2025-12-31 |
| EP4271359B1 (en) | 2025-12-31 |
| CN116635013A (zh) | 2023-08-22 |
| ES3064347T3 (en) | 2026-04-24 |
| EP4023210A1 (en) | 2022-07-06 |
| US12582601B2 (en) | 2026-03-24 |
| EP4271359A1 (en) | 2023-11-08 |
| US20240366502A1 (en) | 2024-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4227390A4 (en) | COMPOSITION CONTAINING A REFRIGERANT FLUID | |
| EP4148096A4 (en) | COMPOSITION | |
| EP4094582A4 (en) | COMPOSITION | |
| DK3924443T3 (da) | Compositions | |
| EP4115893A4 (en) | Anti-tumor composition | |
| EP3565532A4 (en) | ORAL DISPERSIBLE FILM COMPOSITION | |
| EP4279545A4 (en) | COMPOSITION | |
| EP3756471A4 (en) | ORAL INGESTION COMPOSITION | |
| DK3706724T3 (da) | Orale rifamycin-sv-sammensætninger | |
| EP4404919A4 (en) | DRIED NANOPARTICLE COMPOSITIONS | |
| EP4103854A4 (en) | A multipurpose screw | |
| EP4281046C0 (en) | NALTREXONE-BASED COMPOSITIONS | |
| IL283375A (en) | An orally active prodrug of gemcitabine | |
| EP4284362A4 (en) | Formulations | |
| EP4256012C0 (en) | COMPOSITION | |
| EP4219052A4 (en) | CYLINDRICAL CUTTER TWO SIZES | |
| EP4291042C0 (en) | COMPOSITION DERIVED FROM OATS | |
| EP3846831C0 (en) | COMPOSITIONS OF ASSOCIATIONS OF PROBIOTICS | |
| EP4504168A4 (en) | COMPOSITIONS CONTAINING CANNABINOIDS | |
| JP1764353S (ja) | レンチ | |
| IL310652A (en) | Formulations of radiprodil | |
| EP4337751C0 (en) | COMPOSITION | |
| EP4223850A4 (en) | COMPOSITION | |
| EP4217455C0 (en) | COMPOSITION | |
| EP4188088A4 (en) | Formulations |